ProterixBio

ProterixBio is a high-complexity clinical testing laboratory. We develop and commercialize diagnostic solutions to address critical unmet needs in population health and chronic disease care. One of the company’s key focus areas is vulnerable populations, such as those with chronic obstructive pulmonary disease, diabetes, and cardiovascular conditions. The company has developed algorithms that utilize combinations of blood-based biomarkers to identify individuals at high risk of severe outcomes. ProterixBio maintains a rigorous approach to test development, including collaborations with leading academic medical centers and validation of tests in large, carefully curated cohorts.